Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2018

Stockholders' Equity Note [Abstract]

Schedule of Assumptions Used in the Valuation

The assumptions used in the valuation of options granted under the 2017 Plan during the three months ended March 31, 2018 are as follows:

	For the Three Months Ended March 31, 2018
Market value of stock on measurement date	$24.79 to $24.84
Risk-free interest rate	2.47% to 2.83%
Dividend yield	—
Volatility factor	321% to 324%
Term	10.00 years

Share-based Compensation, Stock Options, Activity

Stock option activity for options granted under the 2017 Plan during the three months ended March 31, 2018 is presented in the table below:

	Number of Shares Available		Number of Options Outstanding			Weighted-average Exercise Price		Weighted-average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in Thousands)
Outstanding at July 31, 2017	—		—			—
Total shares authorized	400,000		—			—
Granted	(214,000	)	214,000			$	37.62	9.71
Exercised	—		—			—
Forfeited	40,000		(40,000		)	$	49.93
Balance at December 31, 2017	226,000		174,000			$	34.78	9.71
Annual additional options authorized	101,431		—			—
Granted	(157,050	)	157,050			$	24.81
Exercised	—		—			—
Balance at March 31, 2018	170,381		$	331,050		$	30.05	9.64	$	3,060

Stock option activity for the Pre-2017 Non-Qualified Stock Options for the three months ended March 31, 2018 is presented in the table below:

	Number of Shares	Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in Thousands)
Outstanding at December 31, 2017	2,980,500	$	7.33	7.06	$	46,606
Exercised	—	—
Forfeited	—	—
Outstanding at March 31, 2018	2,980,500	$	7.33	6.8	$	35,310
Exercisable at March 31, 2018	2,698,678	$	7.13	6.67	$	32,523

Warrant activity for the three months ended March 31, 2018 is presented in the table below:

	Number of Shares		Weighted- average Exercise Price		Weighted- average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in Thousands)
Outstanding at December 31, 2017	357,010		$	9.78	5.57	$	4,708
Exercised	(2,400	)	$	10.00
Outstanding at March 31, 2018	354,610		$	9.78	5.35	$	3,333
Exercisable at March 31, 2018	354,610		$	9.78	5.35	$	3,333

Schedule of Nonvested Share Activity

A summary of the status of the Company’s non-vested options granted under the 2017 Plan as of March 31, 2018 and changes during the three months ended March 31, 2018 are presented in the following table:

	Number of Shares	Weighted Average Grant Date Fair Value Per Share
Non-vested at December 31, 2017	174,000	$	34.78
Granted	157,050	$	24.81
Balance at March 31, 2018	331,050	$	30.05
Vested	—	—
Non-vested at March 31, 2018	331,050	$	30.05

A summary of the status of the Company’s non-vested Pre-2017 Non-Qualified Stock Options as of March 31, 2018 and changes during the three months ended March 31, 2018 are presented below:

	Number of Options		Weighted Average Grant Date Fair Value
Non-vested at December 31, 2017	288,902		$	7.87
Vested	(7,080	)	$	7.58
Non-vested at March 31, 2018	281,822		$	7.88